(redirected from Serine protease inhibitor)
Also found in: Dictionary, Thesaurus, Medical, Encyclopedia.
See: deterrent
References in periodicals archive ?
If Phase I studies prove promising, BioCryst plans to evaluate this lead serine protease inhibitor drug candidate's ability to prevent excessive bleeding and inflammatory responses in patients undergoing cardiopulmonary bypass surgery.
We look forward to taking our serine protease inhibitor into clinical development, and we expect to select a lead influenza neuraminidase inhibitor soon.
Through a Sparta-funded grant, Rubin, who is a scientific advisor to the company, has created a new class of recombinant modified human proteins that are specific serine protease inhibitors.
Professor of Medicine at Brown Medical School, to develop products based on the natural serine protease inhibitors, called inter-alpha inhibitor proteins (IaIp).
The serine protease inhibitors have been reported from various plant families with varying inhibition efficacy.
Most of the serine protease inhibitors from different sources have been found to have considerable medical and industrial importance and they are being extensively studied to obtain an insight into mechanisms for understanding the specificity of inhibition of enzyme catalysis.
Curacyte Discovery is engaged in the development of synthetic serine protease inhibitors in the area of hemostasis and anti-coagulation.
The hK6 monoclonal antibody was used as the capture antibody; the rabbit polyclonal hK6 detection antibody was replaced with rabbit antibodies against each of six common serine protease inhibitors ([[alpha].
Arriva and ProMetic formed a joint venture in 1999 to develop and commercialize recombinant alpha 1-antitrypsin (AAT) and other serine protease inhibitors for the treatment of various inflammatory conditions, including dermatological diseases such as atopic dermatitis and psoriasis.
NASDAQ: DYAX) today announced positive initial findings from a research collaboration they established to discover, develop and commercialize novel cancer therapeutics focused on serine protease inhibitors.

Full browser ?